The company can now initiate its phase 1/2 CLARITY trial activities for its lead in vivo genome-editing program GEB-101 for TGFBI corneal dystrophy. NCX 470 is Nicox’s lead dual-mechanism bimatoprost ...

Abstract: Acoustic indoor positioning has been widely studied due to its advantages of low cost, easy deployment, and high accuracy. However, the limitation of insufficient update rates remains a ...

I’ve taught millennial and Gen Z students throughout my career, and the differences in the ways they learn are truly remarkable. Constant exposure to screens has left many experiencing fatigue, apathy ...

NPR's Ailsa Chang talks with Shane O'Neill of The Washington Post about the word "aesthetic" and its evolution from art criticism and design theory to online speak and the White House. So yesterday, ...